ArticleFrontiers in bioinformatics2026
A machine learning-derived genomic dataset from bacteria frequently reported as probiotics.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Probiotics are live microorganisms that have been widely investigated for their association with beneficial host outcomes, particularly in the context of gut-associated microbial communities. Despite extensive literature, the probiotic effects are recognized as strain-specific and highly context-dependent, which limits the identification of universal genetic determinants of probiosis. In this study, we present a machine learning-derived genomic dataset generated from comparative analyses of bacterial genomes belonging to taxa frequently reported as probiotics and reference gut-associated bacteria. Using pangenomic analysis combined with supervised machine learning approaches, including Random Forest, Support Vector Machine, and Logistic Regression, we extracted discriminative genomic features from large-scale genome data. The resulting dataset comprises 1,072 non-redundant protein-coding sequences, accompanied by gene presence-absence matrices and functional annotations. These features should not be interpreted as causal determinants of probiotic functionality, but rather as genomic patterns associated with bacterial taxa commonly used as probiotics, which may also reflect taxonomic and ecological signatures. All data and scripts used in this study are publicly available through an open-access repository, providing a reusable resource for exploratory analyses, comparative genomics, and methodological benchmarking in probiogenomics and microbial genomics. The final data, hereby called ProbioSML, is currently available on https://doi.org/10.5281/zenodo.14181443.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.